Anlotinib hydrochloride
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for Anlotinib hydrochloride, covering 2018-11-02 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer [Phase 2]